Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2023-12
Agios Pharmaceuticals USD 72K 0 2023-12
Alnylam Pharmaceuticals USD 1.26M 4K 2023-12
Amgen USD 32.75B 152M 2023-09
Arrowhead Research USD 200K 0 2023-12
Avrobio USD 4K 0 2023-09
BioMarin Pharmaceutical USD 189K 1000 2023-12
Bluebird Bio USD 1.07M 6K 2023-09
Incyte USD 224K 0 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Moderna USD 38.2K 100 2023-12
Neurocrine Biosciences USD 100K 0 2023-09
PTC Therapeutics USD 75K 0 2023-12
Regeneron Pharmaceuticals USD 102K 0 2023-09
Sarepta Therapeutics USD 9K 0 2023-09
Takeda JPY 1.68T 92M 2023-09
Ultragenyx Pharmaceutical USD 72K 1000 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09
Xencor USD 611K 4K 2023-12



Alnylam Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.